Valtteri Kaasinen
MD, PhD, Professor of Neurology
valtteri.kaasinen@utu.fi |
Clinical Neurology; Movement Disorders; Parkinson's disease; Addictions; Neurotransmitters; Neuroimaging; PET; SPECT; Dopamine System
Movement disorders, neurotransmitters and addictions
Dr. Kaasinen is Professor of Neurology at the University of Turku, and Chief Physician at Neurocenter of Turku University Hospital.
He was appointed as Adjuct Professor of Neurology in 2011, received special competence in medical education in 2016, and was appointed as full Professor of Neurology in 2021.
Dr. Kaasinen is a clinical neurologist and a movement disorder specialist who received his medical degree from the University of Turku in 1996. This was followed by a PhD focusing on brain dopamine PET imaging of Parkinson's disease in 2000. He did his postdoctoral training in 2003-2004 in the University of Groningen, The Netherlands.
Since 2004, he has led a research group that focuses on function brain PET and SPECT neurotransmitter imaging in Parkinson's disease, other movement disorders and behavioral addictions. His group is involved in several project that aim to improve diagnostics and treatment of neurological movement disorders.
Main focus of research is brain function and dysfunction in relation to neurotransmitters, addictions and movement disorders.
Dr. Kaasinen has been involved in curriculum planning and implementation of neurology courses since 2013. He is a personal teacher mentor for medical students and has supervised of several PhD students.
- Bupropion causing misdiagnosis in brain dopamine transporter imaging for parkinsonism (2018)
- Movement Disorders
- Contribution of individual motor signs to striatal dopamine deficiency in parkinsonism (2018)
- Movement Disorders
- Deep brain stimulation for monogenic Parkinson’s disease: A systematic review (2018)
- Movement Disorders
- Dopamine and eye movement control in Parkinson's disease: deficits in corollary discharge signals? (2018)
- PeerJ
- Dopamine synthesis capacity correlates with µ-opioid receptor availability in the human basal ganglia: A triple-tracer PET study (2018)
- NeuroImage
- Edenneen Parkinsonin taudin hoitoa pitää keskittää ja yhdenmukaistaa (2018)
- Duodecim
- No differences in the total burden of non-motor symptoms between Parkinson's disease and non-degenerative parkinsonism (2018)
- Movement Disorders
- Pitkälle edenneen Parkinsonin taudin hoito (2018)
- Parkinson-postia
- Striatal dopamine function in multiple system atrophy and progressive supranuclear palsy: A meta-analysis of imaging studies. (2018)
- Movement Disorders
- Aivojen kuvantaminen Parkinsonin taudin diagnostiikassa (2017)
- Parkinson-postia
- Dopamine and Opioid Neurotransmission in Behavioral Addictions: A Comparative PET Study in Pathological Gambling and Binge Eating (2017)
- Neuropsychopharmacology
- Dopamine transporter imaging does not predict the number of nigral neurons in Parkinson disease (2017)
- Neurology
- Dynamic Changes in Cortical Effective Connectivity Underlie Transsaccadic Integration in Humans (2017)
- Cerebral Cortex
- Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers (2017)
- Movement Disorders
- Parkinsonin taudin varhainen toteaminen ja uudet diagnostiset kriteerit (2017)
- Duodecim
- Serotonin transporter density in binge eating disorder and pathological gambling: A PET study with [11C]MADAM (2017)
- European Neuropsychopharmacology
- Silmäoireinen kuppa (2017)
- Duodecim
- SNCA mutation p.Ala53Glu is derived from a common founder in the Finnish population (2017)
- Neurobiology of Aging
- Striatal dopamine in Parkinson disease: A meta-analysis of imaging studies (2017)
- Annals of Neurology
- Survival in Parkinson's disease in relation to striatal dopamine transporter binding (2017)
- Parkinsonism and Related Disorders